🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Incredibly proud to see my mentor Dr. Konstantin Dragnev presenting PRAGMATICA-LUNG (SWOG S2302) at #ASCO25 ASCO Dartmouth Cancer Center Dartmouth Health While ramu+pembro did not improve OS, this combination was not worse than SOC overall Abstract LBAA8671

Hot topic! Marc Machaalani fantastic IM applicant this upcoming cycle presents data on KIM-1 in JR101 #ASCO25 OncoAlert

I am presenting two posters this afternoon in two different sessions! Come say Hi! #ASCO25

It was a true pleasure to present at the ASCO TECAG Lounge at #ASCO25 on the Keys to Success for an Early Career Oncologist! 🔑 💫 Thanks to Tobe for the excellent moderation and to the entire panel Mina S. Sedrak Muhamad Alhaj Moustafa, MD, MS Tim Brown, MD MSCE ASCO OncoAlert

End of a terrific #ASCO2025 Attended some great sessions, met familiar faces and a shoutout to the ASCO TECAG for their incredible events and organisation!

📍Check out our ASCO poster (Board A136) on the Adequacy of Thyroid Function Monitoring after ICI therapy. ⭐️ Post-ICI thyroid dysfunction is common but often underdiagnosed due to limited surveillance. 🔎 Findings underscore the need for extended TFT monitoring post-treatment.

An #ASCO25 Poster Session Story: The story begins in 2020, when Jasnoor Malhotra (a UC Riverside graduate) babysat for my kids for an afternoon (picture below from 5y ago!). Her mom was my kids AMAZING preschool teacher. Jasnoor expressed interest in going to #medschool & wanted

Excited to present our research today at #ASCO25 ASCO! IMG exhibit higher research productivity compared to AMGs - matrix that helps PDs to recruit more IMGs to hemonc fellowship programs! IMG Oncologists Nazli Dizman Fatemeh Ardeshir, MD Ziad Bakouny, MD, MSc Toni Choueiri, MD Ohio State Medical Oncology

Grateful to everyone who came by and thanks for not pimping me too much on the depths of basic immunology. Thank you to my mentors for these projects Deborah Doroshow, Cardinale B. Smith , Dr. Tom Marron. #ASCO25

Deeply honored to step into the role of 2025-26 ASCO President. My focus will be guided by the theme, "The Science and Practice of Translation: Improving Cancer Outcomes Worldwide." Looking forward to a productive & collaborative year ahead with our incredible ASCO community!

Thanks #ASCO25- you were surely extra special 💕🎀🥰🥳 ✅endowed and handed over the Kamboj Christie YIA award ✅attended CoP - AI, Palliative Oncology, IMG ✅hosted CoP - Policy; ✅presented Advocacy 101 ✅got FASCO W Family/ Friends ✅got Yvonne award for Comminity Oncology

Morning administration of 1L chemoIO nearly doubled OS and PFS compared to afternoon tx in metastatic cancer. 🤯🤯🤯Confirmatory studies needed but SQ IO formulations could help to incorporate this into practice and/or explore in clx trial…? #lcsm ASCO #ASCO25 Bristol Myers Squibb

Has there ever been a more girl boss ASCO TECAG panel? 💪💪💪 Noha N. Soror, MD, MSc. 𓂀 Ana I. Velázquez Mañana, MD, MSc, FASCO Arthi Sridhar Dionisia Quiroga, DO, PhD

We are grateful to our ~44,000 attendees who made #ASCO25 a success & the place to be! With nearly 40% joining us from outside the U.S., we are truly a global community united by our shared goal of improving #CancerCare & pt outcomes around the world. A heartfelt ‘thank you.’ 💗

Fionnuala Crowley ASCO TECAG Ana I. Velázquez Mañana, MD, MSc, FASCO Arthi Sridhar Dionisia Quiroga, DO, PhD Thank you for your kind words, Fin! You’re truly a star. I’m so grateful our paths crossed and for the invaluable friendship!

Thrilled to officially join the 2025–2026 ASCO Trainee & Early Career Advisory Group (ASCO TECAG )! 💼🌟 This powerhouse team brings together trainees from across the country united by a shared mission: championing the next generation of oncologists. Grateful for the

1st time submitting an abstract to #ASCOQLTY25 and so excited to finally attend the conference in the fall!! Grateful to Edward Christopher "Chris" Dee, MD Nishwant Swami, MD, MPH for all the help in putting together our study!

1/5 This comes up in #kidneycancer clinic every few months. And on patient groups just as often. 📊 The ASSURE nomogram shows cumulative disease-free survival (DFS) from time 0 after surgery. Great info… until someone hits the 2-year mark and panics at that 48.8% 3-year number.

Thrilled and grateful to have received the Young Investigator scholarship (YIP) award from Society of Hematologic Oncology (SOHO) for #SOHO25 ! Thankful and grateful for the help and support from Prashanth Ashok Kumar SUNY Upstate IM Residency Upstate Cancer Center Nikhil Vojjala, MD Avi Harisingani, MD

Two articles published in one week - what a week! 🔥 Does metastatic-directed RT improve outcomes in #oligoprogressive #MBC? ⚡60% of patients with oligoprogressive MBC remained on the same systemic therapy for at least 6 months post-MDRT 💥This suggests that MDRT may help